Author

Jaime O. Munoz

Observed names: Jaime Munoz, Jaime Muñoz, Jaime Omar Munoz

Institution: Baylor College of Medicine

Observed institutions: Baylor College of Medicine, Texas Children's Hospital

OpenAlex ID: A5015962959

Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance

2017 · Alexandra M. Stevens, Jennifer M. Miller, et al. · Blood Advances · 80

Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation

2019 · Alexandra M. Stevens, Michael Xiang, et al. · Blood Advances · 59

Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors

2020 · Matthew B. Minus, Haopei Wang, et al. · Organic & Biomolecular Chemistry · 12

CRLF2 overexpression results in reduced B-cell differentiation and upregulated E2F signaling in the Dp16 mouse model of Down syndrome

2022 · Jacob J. Junco, Barry Zorman, et al. · Experimental Hematology · 7

Atovaquone Demonstrates Single Agent Activity and an Additive Effect in Combination with Cytotoxic Chemotherapy (Cytarabine and Daunorubicin) in AML

2017 · Alexandra M. Stevens, Jaime O. Munoz, et al. · Blood · 1

Development of a Pediatric AML Patient Derived Xenograft Program

2022 · Alexandra McLean Stevens, Maci Terrell, et al. · Blood

CRLF2 Overexpression Demonstrates Enhanced Leukemogenicity in Down Syndrome Hematopoietic Cells

2016 · Jacob J. Junco, Shan Liang, et al. · Blood

Works count: 7

Citation count: 159

H-index: 4

I10-index: 3